{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:12:11Z","timestamp":1792800731777,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.ijcard.2025.133227","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T03:38:08Z","timestamp":1743737888000},"page":"133227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["[99mTc]Tc-DPD SPECT\/CT evaluation of right and left ventricular involvement in cardiac transthyretin amyloidosis"],"prefix":"10.1016","volume":"431","author":[{"given":"Katarzyna","family":"Holcman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"Rubi\u015b","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"\u0106miel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Szot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"St\u0119pie\u0144-Wroniecka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Graczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystian","family":"Mr\u00f3z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewa","family":"Dziewi\u0119cka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winiarczyk","family":"Mateusz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylwia","family":"Szczepara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kurek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mateusz","family":"K\u0119ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Podolec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Kostkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2025.133227_bb0005","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133227_bb0010","first-page":"e558","article-title":"2020 AHA\/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"142","author":"Ommen","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.133227_bb0015","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gill Gillmore","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2025.133227_bb0020","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: part 1 of 2-evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0025","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/eurheartj\/ehab072","article-title":"Diagnosis and treatment of cardiac amyloidosis: a position statement of the ESC Working Group on Myocardial and Pericardial Diseases","volume":"42","author":"Garcia-Pavia","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133227_bb0030","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1093\/eurheartj\/ehv338","article-title":"Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction","volume":"36","author":"Gonz\u00e1lez-L\u00f3pez","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133227_bb0035","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1093\/eurheartj\/ehx350","article-title":"Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement","volume":"38","author":"Casta\u00f1o","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133227_bb0040","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1093\/eurheartj\/ehv583","article-title":"Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness","volume":"37","author":"Damy","year":"2016","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2025.133227_bb0045","first-page":"153","article-title":"From hypertrophic cardiomyopathy to transthyretin amyloidosis: an unusual case and challenging diagnosis","volume":"130","author":"Petkow-Dimitrow","year":"2020","journal-title":"Pol. Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2025.133227_bb0050","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s10554-016-1060-4","article-title":"Transthyretin cardiac amyloid and aortic stenosis in the elderly, the role of nuclear imaging","volume":"33","author":"Merli","year":"2017","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ijcard.2025.133227_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2025.133227_bb0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133227_bb0070","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1007\/s12350-023-03297-1","article-title":"Diagnostic accuracy of bone scintigraphy imaging for transthyretin cardiac amyloidosis: systematic review and meta-analysis","volume":"30","author":"Ahluwalia","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0075","article-title":"Pre-symptomatic scintigraphic and genetic cascade screening in cardiac transthyretin amyloidosis","author":"Holcman","year":"2024","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ijcard.2025.133227_bb0085","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"Phelan","year":"2012","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2025.133227_bb0090","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0095","first-page":"1693","article-title":"Transthyretin amyloid cardiomyopathy in patients with unexplained increased left ventricular wall thickness","volume":"40","author":"Holcman","year":"2024","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.5603\/NMR.a2022.0033","article-title":"The scintigraphic diagnosis of cardiac amyloidosis. An expert opinion endorsed by the Section of Nuclear Medicine of the Polish Cardiac Society and the Polish Nuclear Medicine Society","volume":"25","author":"Holcman","year":"2022","journal-title":"Nucl. Med. Rev. Cent. East. Eur."},{"key":"10.1016\/j.ijcard.2025.133227_bb0105","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.33963\/v.kp.97648","article-title":"Diagnosis and treatment of transthyretin amyloidosis cardiomyopathy: a position statement of the Polish Cardiac Society","volume":"81","author":"Grzybowski","year":"2023","journal-title":"Kardiol. Pol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0110","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s12350-022-03149-4","article-title":"Cardiac DPD-uptake time dependency in ATTR patients verified by quantitative SPECT\/CT and semiquantitative planar parameters","volume":"30","author":"Wollenweber","year":"2023","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.jcmg.2017.06.020","article-title":"Regional variation in technetium pyrophosphate uptake in transthyretin cardiac amyloidosis and impact on mortality","volume":"11","author":"Sperry","year":"2018","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0120","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD quantification in cardiac amyloidosis: a novel imaging biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0125","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1093\/ehjci\/jead030","article-title":"Monitoring tafamidis treatment with quantitative SPECT\/CT in transthyretin amyloid cardiomyopathy","volume":"24","author":"Rettl","year":"2023","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"5","key":"10.1016\/j.ijcard.2025.133227_bb0130","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.amjmed.2024.01.006","article-title":"CRISPR-Cas gene editing to the genetic rescue","volume":"137","author":"Goetzl","year":"2024","journal-title":"Am. J. Med."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133227_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/13506129.2023.2239986","article-title":"Correlation of ^99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis","volume":"31","author":"Ungericht","year":"2024","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.ijcard.2025.133227_bb0140","doi-asserted-by":"crossref","first-page":"17271","DOI":"10.1038\/s41598-022-21603-8","article-title":"Reliability and feasibility of visual grading systems and quantitative indexes on [^99mTc]Tc-DPD imaging for cardiac amyloidosis","volume":"12","author":"Bae","year":"2022","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ijcard.2025.133227_bb0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12350-022-02960-3","article-title":"Quantitative ^99mTc-DPD-SPECT\/CT assessment of cardiac amyloidosis","volume":"30","author":"Kessler","year":"2023","journal-title":"J. Nucl. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2025.133227_bb0150","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2967\/jnumed.123.266926","article-title":"Prognostic value of [^99mTc]Tc-DPD quantitative SPECT\/CT in patients with suspected and confirmed amyloid transthyretin-related cardiomyopathy and preserved left ventricular function","volume":"65","author":"Caobelli","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"7","key":"10.1016\/j.ijcard.2025.133227_bb0155","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2967\/jnumed.124.267542","article-title":"Deep learning-enabled quantification of ^99mTc-pyrophosphate SPECT\/CT for cardiac amyloidosis","volume":"65","author":"Miller","year":"2024","journal-title":"J. Nucl. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2025.133227_bb0160","first-page":"171","article-title":"Description of a different quantification method for amyloid burden (DPDload) and validation of SPECT\/CT in cardiac amyloidosis","volume":"42","author":"Mall\u00f3n Araujo","year":"2023","journal-title":"Rev. Esp. Med. Nucl. Imagen Mol."},{"issue":"15","key":"10.1016\/j.ijcard.2025.133227_bb0165","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.123.066524","article-title":"Clinical and prognostic implications of right ventricular uptake on bone scintigraphy in transthyretin amyloid cardiomyopathy","volume":"149","author":"Porcari","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ijcard.2025.133227_bb0170","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00259-024-06981-7","article-title":"Clinical significance of quantitative assessment of right ventricular amyloid burden with [99mTc]Tc-DPD SPECT\/CT in transthyretin cardiac amyloidosis","volume":"52","author":"Zhao","year":"2025","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.ijcard.2025.133227_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2023.131598","article-title":"Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with heart failure with preserved ejection fraction (HFpEF) in United States","volume":"398","author":"Lau","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0180","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.06.006","article-title":"Prevalence of wild type ATTR assessed as myocardial uptake in bone scan in the elderly population","volume":"270","author":"Mohamed-Salem","year":"2018","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131813","article-title":"Tolerability and effectiveness of beta-blockers in patients with cardiac amyloidosis: a systematic review and meta-analysis","volume":"402","author":"Kang","year":"2024","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2025.133227_bb0190","article-title":"Advancing diagnostics and therapy in transthyretin amyloid cardiomyopathy","author":"Holcman","year":"2024","journal-title":"ESC Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325002700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527325002700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T08:06:53Z","timestamp":1753430813000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527325002700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":38,"alternative-id":["S0167527325002700"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133227","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"[99mTc]Tc-DPD SPECT\/CT evaluation of right and left ventricular involvement in cardiac transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2025.133227","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"133227"}}